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Abstract
Objectives: The Warburg effect, a switch from aer-
obic energy production to anaerobic glycolysis,
promotes tumour proliferation and motility by
inducing acidiﬁcation of the tumour microenviron-
ment. Therapies that reduce acidity could impair
tumour growth and invasiveness. I analysed the
dynamics of cell proliferation and of resistance to
therapies that target acidity, in a population of cells,
under the Warburg effect.
Materials and methods: The dynamics of mutant
cells with increased glycolysis and motility has
been assessed in a multi-player game with collec-
tive interactions in the framework of evolutionary
game theory. Perturbations of the level of acidity in
the microenvironment have been used to simulate
the effect of therapies that target glycolysis.
Results: The non-linear effects of glycolysis induce
frequency-dependent clonal selection leading to
coexistence of glycolytic and non-glycolytic cells
within a tumour. Mutants with increased motility
can invade such a polymorphic population and
spread within the tumour. While reducing acidity
may produce a sudden reduction in tumour cell
proliferation, frequency-dependent selection enables
it to adapt to the new conditions and can enable
the tumour to restore its original levels of growth
and invasiveness.
Conclusions: The acidity produced by glycolysis
acts as a non-linear public good that leads to coex-
istence of cells with high and low glycolysis within
the tumour. Such a heterogeneous population can
easily adapt to changes in acidity. Therapies that
target acidity can only be effective in the long term
if the cost of glycolysis is high, that is, under non-
limiting oxygen concentrations. Their efﬁcacy,
therefore, is reduced when combined with therapies
that impair angiogenesis.
Introduction
The Warburg effect
Changes in intra-tumoural metabolism are so common
in tumour development that they are considered one of
the hallmarks of cancer (1). In particular, the switch
from aerobic energy production through oxidative phos-
phorylation to anaerobic energy production through gly-
colysis [the ‘Warburg effect’ (2)] is so common that it is
the basis of ﬂuoro-deoxy-D-glucose positron emission
tomography (FdG PET) (3–7). The up-regulation of gly-
colysis is associated with poor prognosis and high
malignancy, and has implications for therapies (8–12).
For example, as it enables cancer cells to grow under
limiting oxygen concentrations, glycolysis counteracts
the effect of anti-angiogenic therapies (13).
As it occurs even under normal oxygen concentra-
tions, however, the Warburg effect cannot be just an
adaptation to hypoxia, and it has been suggested that it
is, instead, a way for tumour cells to increase their rate
of proliferation compared to normal cells, and improve
their invasiveness (14–18) by increasing acidity of the
microenvironment. This ‘acid-mediated tumour invasion
hypothesis’ is reasonable as glycolysis induces microen-
vironment acidiﬁcation (19–21), and because an acidic
microenvironment promotes the death of normal cells
(22–26), facilitates tumour invasiveness by increasing
extra-cellular matrix degradation (27), inhibits immune
reactions (28) and stimulates release of growth factors
(29). Mathematical models describing these effects (30–
33) suggest that the hypothesis is plausible and that
targeting acidity could help impair tumour progression
and malignancy (17,34–38).
Correspondence: M. Archetti, School of Biological Sciences, University
of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK. Tel.:
+44 (0)1603 591241; E-mail: m.archetti@uea.ac.uk
© 2015 The Authors Cell Proliferation Published by John Wiley & Sons Ltd. 259
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
Cell Prolif., 2015, 48, 259–269 doi: 10.1111/cpr.12169
If the Warburg effect is an adaptation to increase
acidity of the microenvironment, however, a new con-
ceptual problem arises. Switching to anaerobic energy
production through glycolysis is costly as glycolysis is
less efﬁcient than aerobic energy production through
oxidative phosphorylation, thus cells must increase glu-
cose ﬂux to maintain sufﬁcient ATP production. If gly-
colysis increases without concurrent reduction of aerobic
metabolism, on the other hand, cells produce their maxi-
mum energetic potential and there may be no cost for
increased glycolysis. Similarly, glycolysis can have no
cost for a cell during episodes of hypoxia. In these
cases, the Warburg effect presents no difﬁculty. A col-
lective action problem arises when increasing glycolysis
is costly for a cell, but induces a beneﬁcial effect for the
tumour as a whole. A mutant cancer cell with aerobic
metabolism in a population of cells with increased gly-
colysis would not pay that cost and could still exploit
the beneﬁts of living in an acidic microenvironment
(created by its neighbouring cells). Explaining what pre-
vents this from happening is necessary to justify the
acid-mediated tumour invasion hypothesis, an issue that
is addressed by game-theory models.
Game-theory models of the Warburg effect
Acidiﬁcation of the microenvironment is the result of
the diffusion of metabolic products of glycolysis, such
as lactic acid and hydrogen ions, in the extracellular
space (19,20). A cell’s ﬁtness, therefore, depends on the
amount of glycolysis in its neighbourhood, that is, on
how many of its neighbouring cells undergo anaerobic
metabolism. The diffusible products of glycolysis (dif-
ferently from ATP, which is a private good for the cell)
are, in the language of game theory, public goods,
because their effect is not limited to the producer cell. A
cell with aerobic metabolism can enjoy a private beneﬁt
(efﬁcient energy production) by exploiting a public good
(acidity) produced by neighbouring cells with glycolytic
metabolism, raising a collective action problem. The
appropriate analytical tool to analyse such collective
action problems is game theory. While game theory is
used in economics to analyse rational behaviour in
human decision-making, evolutionary game theory (39)
does not assume rational decisions; mutations that pro-
gram a cell to adopt a given phenotype determine that
cell’s strategy, and competition within the populations
(in the case of cancer, clonal selection within the body)
results in differential ﬁtness (proliferation rates) for dif-
ferent phenotypes. Game theory models of cancer have
been developed to study competition between cells
(40–42), tumour–stroma interactions (43) and the
dynamics of growth factor production (44–46).
Basanta et al. (47,48) developed game-theory models
of the Warburg effect in the context of glioma progres-
sion, and found that an invasive phenotype is more likely
to evolve after the appearance of glycolysis, and that con-
ditions favouring anaerobic glycolysis also favour tumour
invasion. One limitation of these models is that they
assume that interactions occur between pairs of cells. As
the products of glycolysis act as diffusible public goods,
however, glycolysis should be modelled as a multi-player
public goods game, rather than as a game with pairwise
interactions; it is known that games with pairwise interac-
tions do not generally have the same results as multi-
player, collective action (public goods) games, in particu-
lar, they underestimate the ﬁtness of populations at mixed
equilibria, which often occur in public goods games (49).
Few attempts have been made to analyse collective inter-
actions in cancer research (42,44–46). Assuming multi-
player interactions is also essential in order to study the
effect of therapies that target acidity, as in multi-player
games a cell’s ﬁtness is a function of the number of cells
with glycolytic metabolism in its neighbourhood; perturba-
tions of this function allow to study the dynamics of ther-
apies. A recent multi-player public goods game model of
the Warburg effect (50), on the other hand, does not take
into account invasive cell types, which is a central feature
of the ‘acid-mediated tumour invasion hypothesis’, and
does not analyse the long-term effects of therapies that tar-
get acidity.
Rationale of the analysis
The purpose of this investigation was to analyse the
dynamics of a population of cancer cells that can switch to
and from anaerobic metabolism and can develop increased
motility. A multi-player public goods game in the frame-
work of evolutionary game theory allows modelling the
impact of therapies that target acidity of the microenviron-
ment, by introducing perturbations at equilibrium. Evolu-
tionary game theory can reveal frequency-dependent
effects that are not apparent from other modelling
approaches, and frequency dependence can lead to non-
intuitive results. As we shall see, one of these results, the
coexistence of different cell types, has fundamental impli-
cations for the stability of therapies that target acidity.
The model
The model is a four-strategy, multi-player public goods
game, in which the ﬁtness of a strategy depends on col-
lective interactions of a number of cells. Cells can gener-
ate energy either through glycolysis (GLY phenotype) or
through oxidative phosphorylation (OXI phenotype). Two
additional phenotypes with corresponding metabolism,
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INV-GLY and INV-OXI, have increased motility. GLY
and INV-GLY cells pay a cost c > 0, due to increased
glycolysis. The beneﬁt b(j) of environmental acidity
(induced by glycolysis) accrues to all cancer types, irre-
spective of whether they have glycolytic metabolism,
and is a function of the sum j of GLY or INV-GLY cells
in the neighbourhood. The size of the neighbourhood is
deﬁned by group size n (which depends on diffusion
range of products of the glycolysis). The beneﬁt func-
tion is modelled by a sigmoid function, which allows
description of various types of synergistic effects (50–
52). To take into account the possibility that high levels
of glycolysis are detrimental to tumour cells (self-poi-
soning), we use a double sigmoid function, monotoni-
cally increasing for j < d and monotonically decreasing
for j > d:
bðjÞ ¼ b1ðjÞ j d n
b2ðjÞ j[ d n

where
b1ðjÞ ¼ ½l1ðjÞ  l2ð0Þ=½l1ðdnÞ  l1ð0Þ
b2ðjÞ ¼ 1 ½l2ðj; yÞ  l2ðdn; yÞ=½l2ðn; 1Þ  l2ðdn; 1Þ
are the normalized versions of the logistic functions
l1ðjÞ ¼ 1
1þ es1 h1j=ndð Þ
l2ðj; yÞ ¼ y
1þ es2 h2j=nd1dð Þ
The parameter d describes the value of j at which the
beneﬁts of acidity are overcome by its deleterious effects;
for j < dn, the function is monotonically increasing and
has an inﬂection point at h1 and steepness s1; for j > dn,
the function is monotonically decreasing and has an
inﬂection point at h2 and steepness s2 (with 0 < h1,h2 ≤ 1
and s1,s2 > 0); the additional parameter y measures the
maximum damage of self poisoning.
In a large population with no assortment, one can
approximate the analysis by assuming an inﬁnite, well-
mixed population, and the ﬁtnesses of GLY and OXI
cells are given by respectively
WGLY ðxÞ ¼
Xn1
j¼0
n 1
j
 
xjð1 xÞn1j  bðjþ 1Þ  c
WOXI ðxÞ ¼
Xn1
j¼0
n 1
j
 
xjð1 xÞn1j  bðjÞ
where 0 ≤ x ≤ 1 is the fraction of GLY and INV-GLY
cells in the population. We assume that invasive pheno-
types, because of their ability to move away when acid-
ity is high, do not suffer self-poisoning. The ﬁtnesses
for the invasive phenotypes are, therefore:
WINVGLY ðxÞ ¼
Xn1
j¼0
n 1
j
 
xjð1 xÞn1j
 b b1ðjþ 1Þ  f½   c
WINVOXI ðxÞ ¼
Xn1
j¼0
n 1
j
 
xjð1 xÞn1j  b b1ðjÞ  f½ 
where the additional parameter b measures the maxi-
mum beneﬁt achieved by the cells and f measures the
cost of increased motility. The ﬁtness functions therefore
assume that the invasive phenotype pays a net cost for
motility at low values of x, whereas when acidity (x) is
high enough, the beneﬁt of motility overcomes its cost.
Parameters are summarized in Table 1, and their effect
on the beneﬁt function is summarized in Fig. 1.
While in models with two strategies or pairwise
interaction, an analytical characterization of the dynam-
ics and of the equilibria is often possible, complexity of
the present model is beyond analytical tractability. Thus,
I analysed the dynamics by simulation assuming stan-
dard, deterministic replicator dynamics. Therapies that
reduce acidity of the tumour microenvironment are mod-
elled as perturbations of the equilibrium: when cell type
frequencies are stable, the contribution of each GLY or
INV-GLY cell to acidity is reduced to a fraction ξ of
the original contribution. The population is then allowed
to evolve under the new conditions, in which each cell
with a glycolytic metabolism only contributes ξ to the
overall acidity of the microenvironment.
Results
Coexistence or extinction
When the invasive phenotype produces energy by anaer-
obic metabolism (INV-GLY), it generally goes to ﬁxa-
tion, driving both GLY and OXI phenotypes to
extinction; an invasive phenotype that produces energy
by oxidative phosphorylation (INV-OXI), instead, gener-
ally coexists with the GLY phenotype (while the OXI
phenotype becomes extinct). Tumour ﬁtness is higher in
the former case. The ﬁnal composition of the population
does not depend on the initial frequencies of the three
phenotypes (Fig. S1).
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If both invasive phenotypes are present, however,
they (INV-GLY or INV-OXI) always coexist at equilib-
rium, unless the initial frequency of the GLY phenotype
is low enough and c is high enough (Fig. 2). In this lat-
ter case, there are not enough GLY cells for glycolysis
to evolve and therefore not enough acidity for invasive
phenotypes to proliferate. In what follows, unless stated
otherwise, I assume that aerobic metabolism (OXI) is
the original condition of the cell population and a small
fraction (0.001, unless stated otherwise) of GLY and
invasive cells (INV-GLY or INV-OXI) arise in this popu-
lation.
Effect of the parameters on the dynamics
If the only invasive phenotype in the population has aer-
obic metabolism (INV-OXI) (Fig. S2), it will coexist
with GLY if h1 is low; if h1 is high, and if d or c are
high enough, instead, the OXI phenotype can even drive
INV-OXI and GLY cells to extinction. When two types
coexist, ﬁtness decreases with h1 and d, with c and b,
and increases with s1; when the INV-GLY phenotype
goes to ﬁxation, however, ﬁtness is higher for higher
values of h1; GLY and INV-OXI can coexist and fre-
quency of GLY increases with d and decreases with c,
s1 and b; however, if h1 is high enough and d or c is
too high, both GLY and INV-OXI become extinct and
are replaced by OXI (Fig. S2). In short: a mutant INV-
OXI phenotype generally leads to a polymorphic popu-
lation in which it coexists with the GLY type or (if the
cost of glycolysis is too high or the beneﬁts of acidity
require a large faction of cells with glycolytic metabo-
lism) to a monomorphic population made of OXI cells.
If only the invasive phenotype with glycolytic
metabolism (INV-GLY) is present (Fig. S2), INV-GLY
either becomes extinct (for high d and high h1), leading
to the ﬁxation of the OXI phenotype, or drives the other
types to extinction (if c is low); it can only coexist with
OXI if c is high, whereas GLY and OXI coexist only if
the cost of motility is extremely high compared to its
beneﬁt (high f, low b) (Fig. S2). In short: a mutant
INV-GLY phenotype generally leads to a monomorphic
population, either of itself or (if the cost of glycolysis is
too high or beneﬁts of acidity require a large faction of
cells with glycolytic metabolism) of the OXY type.
While the two invasive mutant types individually
lead to either a monomorphic population of OXY cells
Table 1. Summary of the parameters
c Cost of glycolysis
x Frequency of cells with increased glycolysis in the population
j Number of cells with increased glycolysis in the neighbourhood
n Neighbourhood size
d Value of (j/n) above which b decreases with j (self-poisoning)
h1 Inﬂection point of b for j < dn
h2 Inﬂection point of b for j > dn
s1 Steepness of b at h1
s2 Steepness of b at h2
b Beneﬁt of completely acidic environment
y Cost of maximum level of self poisoning
f Cost of increased motility
ξ Fraction of the original acidity left after therapy
Figure 1. Effect of the parameters on the beneﬁt function. The
beneﬁt of glycolysis-induced acidity is plotted as a function of the
fraction (x) of GLY and INV-GLY cells. The continuous line shows the
beneﬁt b(j) for the non-invasive phenotypes GLY and OXI; the dashed
line shows the beneﬁt b[b1(j)  f] for the invasive phenotypes INV-
GLY and INV-OXI. Self-poisoning occurs for x > d for the non-inva-
sive phenotypes. The inﬂection point of the function is h1 for x < d
and h2 for x > d. The steepness of the function is s1 for x < d and s2
for x > d. The maximum amount of self-poisoning is y. The maximum
cost of motility is f. The beneﬁt of motility is b. The larger plot shows
the functions for GLY and for INV-GLY for h = 0.5, d = 0.6, s = 20,
y = 1.5, f = 0.1, b = 1.2. The smaller plots show the effect of chang-
ing individual parameters. In all cases, group size n = 20; s2 = 20;
h2 = 0.5.
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or to a stable coexistence of GLY and INV-OXI,
when both invasive phenotype are present, the dynamics
are more complex, but the results are rather simple: OXI
and GLY types become extinct, unless the cost of
motility is large enough (f > 0.2) (Fig. 3). When the
two invasive phenotypes coexist, the frequency of INV-
GLY decreases with c (the cost of glycolysis) and
increases with h1 (that is, INV-GLY is more common
when higher acidity is necessary for proliferation and
motility), d (that is, INV-GLY is more common when
self-poisoning is triggered by higher acidity) and b (that
is, INV-GLY is more common when the beneﬁt of
motility is higher).
In all cases, the details of self-poisoning (values of
y, h2 and s2) are largely irrelevant to the dynamics (even
in a model in which self-poisoning is introduced in the
invasive types).
Effects of therapies that reduce acidity of the
microenvironment
The short-term effect of reducing acidity is a reduction in
tumour ﬁtness. If the population is at a polymorphic equi-
librium, however, the frequencies of the two types change
following the new acidity level: the fraction of GLY cells
increases, leading to a new increase in acidity and tumour
growth; if the reduction in acidity is small (high ξ), the
population has, at the new equilibrium, approximately the
same ﬁtness as before treatment (Fig. S3), although inva-
siveness declines. In the presence of the INV-GLY pheno-
type, instead, tumour growth declines and remains
constant, but invasiveness does not decline as the popula-
tion is, in this case, monomorphic.
If both invasive phenotypes are present (Fig. 4),
reducing acidity has the same immediate effect: a
(a)
(b)
Figure 2. Effect of initial frequencies on
the dynamics with both types of invasive
cell. (a) Changes over time of the frequencies
of the four cell types and of tumour ﬁtness
starting from different initial frequencies.
h1 = h2 = 0.5, d = 0.6, s1 = s2 = 20, y = 1.5,
f = 0.1, b = 1.2, n = 20. (b) Frequencies and
tumour ﬁtness at equilibrium as functions of
the initial frequency of the GLY type; the ini-
tial frequency of the other cell types is 0.01
for INV-GLY and INV-OXI, and all the rest
are OXY cells.
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reduction in tumour cell proliferation. If acidity is not
reduced enough, however (ξ is high) the fraction of
INV-GLY cells increases at the expense of INV-OXI,
irrespective of the cost of glycolysis, and a similar ﬁt-
ness level is restored at the new equilibrium; in fact, ﬁt-
ness at the new equilibrium can be even higher (Fig. 5).
Invasiveness remains unaffected as both types present at
the initial equilibrium have high motility. If the reduc-
tion of acidity is large enough (ξ is high), the treatment
can effectively stop tumour cell proliferation; the fre-
quencies evolve to a stable monomorphic population of
either the INV-GLY phenotype (if the cost of glycolysis
is low, for example, under low oxygen concentrations,
when glycolysis is more efﬁcient), or the INV-OXI phe-
notype (if the cost if high). Invasiveness, however, is
not reduced overall.
Finally, a lower value of ξ, that is, a larger reduction
in acidity, is necessary to make the treatment effective
when the value of h1 is low (Fig. 5), that is, when
few cells are enough to induce enough acidity in the
microenvironment to enable cells with high motility to
proliferate.
Discussion
Summary of the results
As acidity induced by glycolysis enhances proliferation
of cancer cells irrespective of their metabolism, selection
for increased glycolysis within a tumour is frequency-
dependent and leads to a stable coexistence of cells with
aerobic and anaerobic metabolism. Such a polymorphic
Figure 3. Effect of the parameters on the
equilibrium and on tumour ﬁtness with
both types of invasive cell. Tumour ﬁtness
and cell type frequencies as a function of c
(the cost of glycolysis for GLY and INV-GLY
cells), d (the fraction of GLY and INV-GLY
cells above which self-poisoning starts) or s
(the steepness of the beneﬁt function at the
inﬂection point for x < d), for different values
of h1 (the inﬂection point of the beneﬁt func-
tion for x < d, or as a function of b (the scal-
ing factor of the beneﬁt for invasive cells) for
different values of f (the cost of motility).
Other parameters: d = 0.6, c = 0.01,
h2 = 0.5, n = 20, s1 = s2 = 20, y = 1.5,
f = 0.1; b = 1.2.
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population can be invaded by mutant subclones with
increased motility, and is the basis for the evolution of
resistance to therapies that target acidity. Analysing the
dynamics and stability of the system reveals how such
therapies could be more effective. These points will be
discussed in detail below.
The Warburg effect leads to intra-tumour heterogeneity
A game theoretic model of tumour proliferation has
been analysed, in which cells can adopt aerobic or
anaerobic metabolism, and can mutate to have high
motility. High motility has a cost for the cell, but it also
has an advantage if the microenvironment is acidic
enough. Gatenby and others (15–18) have proposed that
the beneﬁt conferred by acidity, rather than aerobic
energy production per se, is the adaptive value that
promotes the Warburg effect in tumours – a hypothesis
that seems justiﬁed by the fact that glycolysis is often
up-regulated, even under normal oxygen concentrations.
This ‘acid-mediated tumour invasion hypothesis’,
however, raises a conceptual problem; as the effects of
acidity are not restricted to cells with glycolytic metabo-
lism, glycolysis is a public good, that is, a form of
cooperation among cancer cells. A mutant cell that
reverted to aerobic energy production would beneﬁt
from more efﬁcient metabolism while still enjoying the
advantage of an acidic microenvironment produced by
its neighbouring cells. Game theory can explain how
glycolysis is maintained in spite of this ability of mutant
cells to ‘free-ride’ on glycolysis of other cells.
As we have seen, if the rate of proliferation of a cancer
cell is a non-linear function of acidity produced by glycol-
ysis, frequency-dependent selection leads to coexistence
Figure 4. Dynamics of therapies that
reduce acidity with both invasive cell types.
Acidity is reduced to a fraction ξ = 0.5 or 0.2
at generation 1000. h1 = 0.5, d = 0.6,
h2 = 0.5, n = 20, s1 = s2 = 20, y = 1.5,
f = 0.1; b = 1.2.
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of glycolytic and non-glycolytic cell types within the
tumour. Coexistence results from the fact that products of
glycolysis act as non-linear public goods, and therefore
enable coexistence of cells with aerobic and anaerobic
metabolism. As we have seen here, this form of coopera-
tion between cancer cells remains stable in the presence
of mutant cells with increased motility. These invasive
cells require an acidic microenvironment to thrive and
would not be able to proliferate in the absence of enough
glycolytic cells. The Warburg effect, therefore, leads to
heterogeneity for energy production within the tumour,
which enables meastasis of invasive phenotypes, which
can also persist as a stable polymorphism.
Heterogeneity can lead to resistance against therapies
that target acidity
The stable polymorphism predicted by the model is the
basis of the development of resistance to therapies that
aim to reduce acidity of the microenvironment. Impair-
ing glycolysis may induce short-term reduction of
tumour growth and invasiveness, and it has been sug-
gested (17) that this may be achieved through glucose
deprivation, inhibition of the glycolytic pathway, of glu-
cose transport, or by targeting (for example, by inhibit-
ing its transcription) the hypoxia-inducible factor HIF. It
appears that existing therapies that aim to inhibit glycol-
ysis alone do not show signiﬁcant anti-tumour effects,
and are generally used in combination with other
therapies (17).
The predicted polymorphism of a cell population
under the Warburg effect may help explain the evolution
of resistance to therapies that target acidity. While a
monomorphic population can adapt to new conditions
(hence, therapies) only by clonal selection of new
mutants that arise in the course of the treatment, if a
population is polymorphic it can adapt to new condi-
tions simply by changing the frequencies of the cell
Figure 5. Summary of the effect of therapies that reduce acidity. After the population has reached an equilibrium, acidity is reduced to a frac-
tion ξ of the original value, and the population reaches a new equilibrium. The plots show the difference in ﬁtness, glycolysis (x, the sum of the fre-
quencies of the GLY and INV-GLY phenotypes) and invasiveness (the sum of the frequencies of the INV-GLY and INV-OXI phenotypes) between
the new and the original equilibrium, as a function of ξ, for different values of c and h. Other parameters: d = 0.6, h2 = 0.5, n = 20, s1 = s2 = 20,
y = 1.5, f = 0.1; b = 1.2.
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types already present. This seems to be the case here.
Unfortunately, therefore not only is the Warburg effect
itself an adaptation of the tumour to improve prolifera-
tion and invasiveness; in addition, the resulting hetero-
geneity is an obstacle for therapies that target acidity.
Increasing oxygen level can make therapies more
effective
As we have seen, therapies that reduce acidity can be
effective if the cost of glycolysis is high enough. When
glycolysis provides higher beneﬁts to cells, that is under
limiting oxygen concentrations, the relative cost of gly-
colysis is lower; hypoxia, therefore, would promote the
evolution of resistance to therapies that target acidity.
On the other hand, allowing a sufﬁcient oxygen level
would increase the relative cost of glycolysis, reducing
the possibility of relapse. This means that effectiveness
of such therapies would be compromised by concurrent
administration of drugs that impair angiogenesis.
This seems to be in contrast with the conclusion of
Basanta et al. (48) that anti-angiogenic treatments would
be beneﬁcial for therapies that target glycolysis [see also
(17)] as they reduce the fraction of glycolytic (invasive
or not) cell types. The discrepancy, however, may be
due only to a difference in the modelling approach. In
Basanta et al. (48), angiogenesis was induced by growth
factors produced by glycolytic cell types, and therapies
that reduced angiogenesis had a direct impact on these
two types, which are indeed the ones whose growth was
reduced (in their model) by anti-angiogenic treatment. In
the model presented here, instead, cancer cells do not
induce angiogenesis themselves. Basanta et al. (48)
showed that the fraction of glycolytic invasive cell type
declined with the cost of glycolysis, which is consistent
with the predictions of the present model.
We have also seen that therapies that target acidity
must be more effective to be stable in the long term, as
the number of glycolytic cells required to produce acid-
ity decreases. An empirical measure of this number, of
the diffusion range of products of glycolysis and, in
general, of the other parameters of the model would
help establish whether the proposed therapies (17) that
target acidity could be evolutionarily stable.
Experimental tests
While the main results (frequency-dependent selection
leading to stable heterogeneity and resilience to changes
in acidity) are largely independent of their exact values,
it would be useful to measure the parameters of the
model. Estimating the shape of the beneﬁt function
requires measuring the diffusion range of the products
of glycolysis (which determines neighbourhood size); if
this was known, it would be possible to estimate the
shape of the beneﬁt function by measuring the growth
of populations with different fractions of glycolytic cells.
The cost of glycolysis should also be measured.
While aerobic metabolism is less efﬁcient than aero-
bic energy production through oxidative phosphoryla-
tion, and while we have assumed a cost for increased
glycolysis, there are cases in which increasing glycolysis
or switching to anaerobic metabolism is not costly. Cells
can increase glycolysis without reducing their aerobic
metabolism, thus creating their maximum energetic
potential, which may be helpful (and not costly) during
periods of fast growth with non-limiting resources; gly-
colysis can also be cost-free during episodes of hypoxia.
In these cases, clearly the Warburg effect poses no
difﬁculty, and frequency-dependent selection is not nec-
essary to explain the up-regulation of glycolysis. Fre-
quency-dependent selection, driven by collective
interactions, explains however how the Warburg effect
makes sense when glycolysis has a cost.
If there is a cost for glycolysis, a mixed equilibrium
is stable as the marginal advantage of increasing glycol-
ysis declines with the fraction of cells with high glycol-
ysis, and at some point it is offset by the cost, even
without self-poisoning (50). In other words, when gly-
colysis is costly for a cell and produces a collective ben-
eﬁt for the tumour, a mixed equilibrium is stable even
without self-poisoning. On the other hand, if there is no
cost for glycolysis, the glycolytic type would go to ﬁxa-
tion in the absence of self-poisoning. With self-poison-
ing, however, the fraction of glycolytic cells remains at
intermediate levels simply because too much glycolysis
is deleterious, irrespective of frequency-dependent
selection.
Future theoretical work
As we have seen here, in models that allow both types
of cells (glycolytic or not) to give rise to mutants with
increased motility, types with higher motility always
invade a polymorphic population, and therefore spread
within the tumour (provided the cost of motility is low
compared to its beneﬁts). Motility, therefore, is not an
essential component of the model and could be ignored
in future analyses. This does not mean, of course, that
increased motility is not an essential feature of tumour
dynamics; it simply means that, because we can always
expect increased motility to be favoured by clonal selec-
tion, there is no need to model it explicitly. This was
not obvious in the light of previous results (47,48,50).
With hindsight, not taking motility explicitly into
account is an advantage for future studies, as models
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with only two types are more amenable to analytical
study.
The most signiﬁcant omission in this and previous
models of the Warburg effect is the lack of explicit spa-
tial structure. The model assumes a well-mixed popula-
tion, and spatial structure is known to have signiﬁcant
effects on the dynamics of cooperative interactions (52).
An extension of this multi-player game to a spatially
structured population would be an important theoretical
improvement. Furthermore, the Warburg effect often
characterizes only the hypoxic domain of the tumour,
and the tumour uses lactate from glycolysis as a source
of energy through a lactate shuttle between hypoxic and
oxygenated cells (53–56). This spatial effect has been
recently modelled (56), assuming however pairwise inter-
actions between groups of cells, a model that would also
beneﬁt from an extension to multi-player interaction.
Conclusions
Overall, the results presented here support the idea that
glycolysis-induced acidity is an adaptation of the tumour
to improve competition against healthy cells and inva-
siveness, although they also raise issues with the idea
that acidity can be exploited as a treatment, and make
predictions about interactions with anti-angiogenic thera-
pies that appear to contradict previous results. The long-
term effects of therapies based on perturbations of
microenvironment acidity are rather complex; analysing
cell interactions in the framework of evolutionary game
theory can, besides helping understand the logic of the
Warburg effect, help understand the dynamics of such
therapies.
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Fig. S1. Effect of initial frequencies on the dynamics
with only one type of invasive cell.
Fig. S2. Effect of the parameters on the equilibrium
and on tumour ﬁtness with only one type of invasive
cell.
Fig. S3. Dynamics of therapies that reduce acidity
with only one invasive cell type.
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